Skip to content

Pulmonary Fibrosis & Genetic Factors

Search Clinical Trials

Trial Objectives


The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.  Finding the genes which play a role in pulmonary fibrosis is the first step at developing better methods for early diagnosis and improved treatment for pulmonary fibrosis. The overall hypothesis is that inherited genetic factors predispose individuals to develop pulmonary fibrosis.

The study requires the following:

  • For affected individuals, we confirm your diagnosis by reviewing your medical records. We also ask for a history questionnaire to be filled out and obtain a sample of blood or tissue for genetic studies.
  • Unaffected family members are screened with a questionnaire, and a blood sample is obtained for genetic studies.  Some family members may qualify to undergo high-resolution CT (HRCT) scan for the study.

Who Can Participate


The only requirement for this study is to have at least 2 members of your family diagnosed with Idiopathic Pulmonary Fibrosis (IPF).  You may be included in this number.

Age: Not Specified Gender Any

Estimated Time Commitment


Not Specified

Payment & Reimbursement


Payment Not Provided

Travel Reimbursement Not Available

Trial Contact


For more information, contact:

Rachel Warren
303.724.8569

Request More Information

Trial Location


National Jewish Main Campus, Denver, CO

Trial Sponsors


National Jewish Health

Principal Investigators

Kevin K. Brown

Kevin K. Brown, MD

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required